Lisa M. Clayton
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lisa M. Clayton has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Joshua J. Solano
Florida Atlantic University, Charles E. Schmidt College of Medicine, Department of Emergency Medicine, Boca Raton, Florida
7 shared publications - Patrick G. Hughes
Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City, UT, USA
7 shared publications - Richard D. Shih
Department of Emergency Medicine, Charles E. Schmidt College of Medicine, Florida Atlantic University, 777 Glades Road, Boca Raton, FL 33431, USA
7 shared publications - Scott M. Alter
Department of Emergency Medicine, Florida Atlantic University Charles E. Schmidt College of Medicine, Boca Raton, Florida, USA
7 shared publications - Alexander M. Busko
Critical Care, University of Alabama at Birmingham, Birmingham, USA
1 shared publication Anabelle N. Taveras
Florida Atlantic University Charles E. Schmidt College of Medicine, Department of Emergency Medicine, Boca Raton, Florida
1 shared publication
Latest Publications
- Open Access
- 10 July 2025
- Published by Hapres in Advances in Geriatric Medicine and Research
- Vol. 7 (3)
Lack of Fall Concern and Primary Care Physician Follow-Up in Geriatric Emergency Department Patients with Head Trauma from a Fall
Background: Falls are the leading cause of fatal and nonfatal injuries in the United States for adults aged 65 years and older. The objective of this study was to determine the impact of patient self-perceived concern about falling on subsequent primary care provider (PCP) follow-up in older emergency department (ED) adults who sustained a head injury from a fall. Methods: This was a secondary analysis of a large prospective study which included patients aged ≥65 years who had sustained head trauma from a fall. Patients with penetrating injuries, injury >24 h prior to presentation, and transfer from another hospital were excluded. Participants were telephonically followed up 14 days after ED presentation. They were asked about their concern for a repeat fall and whether they had followed-up with their PCP since discharge. Results: Of 1527 participants surveyed, 769 (50.4%) were concerned about falling again and 758 (49.6%) were slightly or not at all concerned. There was an overall low PCP follow-up rate. The follow up rate was slightly higher for those concerned vs. not concerned about falling (62% vs 56%, p = 0.035; OR = 1.25, 95% CI: 1.01–1.53). Conclusions: Geriatric ED patients who suffered head injury from a fall and expressed concern about future falls were more likely to follow up with their PCP. Fifty percent of participants with a self-reported fall expressed little to no concern for falling again. This suggests that many ED patients that have fallen are vulnerable to deficient PCP follow-up and fall prevention strategies. We suggest increased physician and patient education to emphasize fall prevention and PCP follow-up.
- 10 July 2025
- Published by Hapres in Advances in Geriatric Medicine and Research
- Vol. 7 (3)
Open AccessLack of Fall Concern and Primary Care Physician Follow-Up in Geriatric Emergency Department Patients with Head Trauma from a Fall
Background: Falls are the leading cause of fatal and nonfatal injuries in the United States for adults aged 65 years and older. The objective of this study was to determine the impact of patient self-perceived concern about falling on subsequent primary care provider (PCP) follow-up in older emergency department (ED) adults who sustained a head injury from a fall. Methods: This was a secondary analysis of a large prospective study which included patients aged ≥65 years who had sustained head trauma from a fall. Patients with penetrating injuries, injury >24 h prior to presentation, and transfer from another hospital were excluded. Participants were telephonically followed up 14 days after ED presentation. They were asked about their concern for a repeat fall and whether they had followed-up with their PCP since discharge. Results: Of 1527 participants surveyed, 769 (50.4%) were concerned about falling again and 758 (49.6%) were slightly or not at all concerned. There was an overall low PCP follow-up rate. The follow up rate was slightly higher for those concerned vs. not concerned about falling (62% vs 56%, p = 0.035; OR = 1.25, 95% CI: 1.01–1.53). Conclusions: Geriatric ED patients who suffered head injury from a fall and expressed concern about future falls were more likely to follow up with their PCP. Fifty percent of participants with a self-reported fall expressed little to no concern for falling again. This suggests that many ED patients that have fallen are vulnerable to deficient PCP follow-up and fall prevention strategies. We suggest increased physician and patient education to emphasize fall prevention and PCP follow-up.
- 4 January 2023
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 65, 168-171
Comparing rates of skull fractures in female versus male geriatric patients who sustain head injuries
- 4 January 2023
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 65, 168-171
Comparing rates of skull fractures in female versus male geriatric patients who sustain head injuries
- Open Access
- 22 December 2022
- Published by Springer Nature in Cureus
- Vol. 14 (12)
The Role of Thromboelastography in Identifying Coagulopathy Among Geriatric Traumatic Brain Injury Patients
Background The geriatric population has the highest incidence of head injury, and those who are anticoagulated have an increased risk of traumatic intracranial hemorrhage (ICH). The availability of viscoelastic coagulation studies has coincided with the development of many anticoagulation reversal agents. In this study, our objective was to assess whether the thromboelastography (TEG) assay affected clinical decision-making regarding reversal agent administration among geriatric patients with ICH caused by blunt head trauma. Methodology We prospectively screened adults aged 65 and older with head trauma presenting to the emergency departments of two level-one trauma centers. International Classification of Diseases, Tenth Revision codes S00-09 were used to identify the diagnosis of head injury. Patients with CT head imaging positive for acute ICH were included. Each patient was assessed for home use of antiplatelet or anticoagulant medications, as well as in-hospital use of any reversal agents. Reversal agent administration and mortality were compared between patients who received TEG and those who did not. Results A total of 680 patients had acute ICH on head CT, and 324 (48%) patients received TEG. More patients screened with TEG were transfused platelets (30.2% vs. 10.7%, p < 0.001). This remained significant for patients taking anticoagulants, antiplatelets, or neither. There were no differences in the administration of other reversal agents (prothrombin complex concentrate or fresh frozen plasma) or mortality whether or not TEG was performed. Conclusions Patients who had TEG performed were more likely to receive platelet reversal agents, regardless of antiplatelet medication usage. Among elderly adults with ICH, TEG is a rapid screening test that may help identify patients with platelet function abnormalities requiring reversal.
- 22 December 2022
- Published by Springer Nature in Cureus
- Vol. 14 (12)
Open AccessThe Role of Thromboelastography in Identifying Coagulopathy Among Geriatric Traumatic Brain Injury Patients
Background The geriatric population has the highest incidence of head injury, and those who are anticoagulated have an increased risk of traumatic intracranial hemorrhage (ICH). The availability of viscoelastic coagulation studies has coincided with the development of many anticoagulation reversal agents. In this study, our objective was to assess whether the thromboelastography (TEG) assay affected clinical decision-making regarding reversal agent administration among geriatric patients with ICH caused by blunt head trauma. Methodology We prospectively screened adults aged 65 and older with head trauma presenting to the emergency departments of two level-one trauma centers. International Classification of Diseases, Tenth Revision codes S00-09 were used to identify the diagnosis of head injury. Patients with CT head imaging positive for acute ICH were included. Each patient was assessed for home use of antiplatelet or anticoagulant medications, as well as in-hospital use of any reversal agents. Reversal agent administration and mortality were compared between patients who received TEG and those who did not. Results A total of 680 patients had acute ICH on head CT, and 324 (48%) patients received TEG. More patients screened with TEG were transfused platelets (30.2% vs. 10.7%, p < 0.001). This remained significant for patients taking anticoagulants, antiplatelets, or neither. There were no differences in the administration of other reversal agents (prothrombin complex concentrate or fresh frozen plasma) or mortality whether or not TEG was performed. Conclusions Patients who had TEG performed were more likely to receive platelet reversal agents, regardless of antiplatelet medication usage. Among elderly adults with ICH, TEG is a rapid screening test that may help identify patients with platelet function abnormalities requiring reversal.
- Open Access
- 17 September 2022
- Published by Springer Nature in Cureus
- Vol. 14 (9) , e29247
The Treatment of COVID-19 With Monoclonal Antibody Therapy: Patient-Reported Outcomes
There have been many efforts to research and produce treatment modalities for COVID-19. Monoclonal antibodies have been one of the effective treatments since their approval by the US Food and Drug Administration (FDA) under emergency use authorization (EUA) in 2020. This study surveyed COVID-19 patients about their disease course and experience with monoclonal antibody treatment. Patients who received monoclonal antibody treatment between February 12, 2021, and June 2, 2021, at a South Florida community hospital were enrolled in the study. This included patients over 18 years of age with a confirmed positive COVID-19 test result, with mild to moderate symptoms within 10 days of onset and identified as high risk for progression to severe disease. There were no exclusion criteria. After 30 days, patients were followed up via a structured telephone survey regarding subsequent emergency department (ED) visits for worsening COVID-19 symptoms, need for oxygenation, intubation, and death. Secondary outcomes were adverse effects and patient perceptions. Among the 119 patients who received monoclonal antibodies during the established time frame, 93 (78.1%) consented to participate in the telephone survey. Of these, 11.8% had a subsequent visit to the ED for worsening COVID-19 symptoms, 6.5% required oxygen, and 2.2% were admitted to the intensive care unit (ICU). There were no reported intubations or deaths. The vast majority (91.4%) would recommend monoclonal antibody treatment to others. Patients who received monoclonal antibody therapy had low rates of subsequent ED visits and rarely required oxygen or ICU admission. The majority of patients would recommend treatment with monoclonal antibodies to others.
- 17 September 2022
- Published by Springer Nature in Cureus
- Vol. 14 (9) , e29247
Open AccessThe Treatment of COVID-19 With Monoclonal Antibody Therapy: Patient-Reported Outcomes
There have been many efforts to research and produce treatment modalities for COVID-19. Monoclonal antibodies have been one of the effective treatments since their approval by the US Food and Drug Administration (FDA) under emergency use authorization (EUA) in 2020. This study surveyed COVID-19 patients about their disease course and experience with monoclonal antibody treatment. Patients who received monoclonal antibody treatment between February 12, 2021, and June 2, 2021, at a South Florida community hospital were enrolled in the study. This included patients over 18 years of age with a confirmed positive COVID-19 test result, with mild to moderate symptoms within 10 days of onset and identified as high risk for progression to severe disease. There were no exclusion criteria. After 30 days, patients were followed up via a structured telephone survey regarding subsequent emergency department (ED) visits for worsening COVID-19 symptoms, need for oxygenation, intubation, and death. Secondary outcomes were adverse effects and patient perceptions. Among the 119 patients who received monoclonal antibodies during the established time frame, 93 (78.1%) consented to participate in the telephone survey. Of these, 11.8% had a subsequent visit to the ED for worsening COVID-19 symptoms, 6.5% required oxygen, and 2.2% were admitted to the intensive care unit (ICU). There were no reported intubations or deaths. The vast majority (91.4%) would recommend monoclonal antibody treatment to others. Patients who received monoclonal antibody therapy had low rates of subsequent ED visits and rarely required oxygen or ICU admission. The majority of patients would recommend treatment with monoclonal antibodies to others.
- 1 July 2022
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 59, 152-155
Time from hospital presentation to head imaging in White, Black, and Hispanic geriatric trauma patients
- 1 July 2022
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 59, 152-155
Time from hospital presentation to head imaging in White, Black, and Hispanic geriatric trauma patients
- Open Access
- 21 June 2022
- Published by Springer Nature in Cureus
- Vol. 14 (6) , e26176
Controversial COVID-19 Cures: Hydroxychloroquine and Oleander Pediatric Ingestion Simulation Cases
Introduction: The use of hydroxychloroquine has dramatically increased since being touted as a potential therapeutic in combating coronavirus disease 2019 (COVID-19) caused by the SARS-CoV-2 virus. This newfound popularity increases the risk of accidental pediatric ingestion, whereby just one or two tablets causes morbidity and mortality from seizures, cardiac dysrhythmias, and cardiogenic shock. The unique management of hydroxychloroquine overdose makes it imperative for emergency medicine physicians to have familiarity with treating this condition. Similarly, during the COVID-19 pandemic, there have been publicized cases touting extracts of oleander as being a potential therapeutic against the illness. Since it is commonly available and potentially lethal ingestion with a possible antidote, we developed a simulation case based on the available literature. The two cases were combined to create a pediatric toxicology curriculum for emergency medicine residents and medical students. Both of these treatments were selected as simulation cases since they were being touted by prominent national figures as potential cures for COVID-19. Methods: Two series of simulation cases were conducted in a high-fidelity simulation lab with emergency medicine residents and medical students. The hydroxychloroquine simulation case involved the management of a four-year-old male who presented to the emergency department with nausea, vomiting, and tachycardia after ingesting hydroxychloroquine tablets. As the case unfolded, the child became increasingly unstable, eventually experiencing QT prolongation, torsades de pointes, and ventricular fibrillation arrest requiring appropriate resuscitation to achieve a return of spontaneous circulation. The oleander simulation case involved the management of a three-year-old male who presented to the emergency department with nausea, vomiting, and tachycardia after ingesting parts of an unknown plant. As that case progresses, the child becomes increasingly unstable, eventually experiencing atrial fibrillation, bradycardia, and degenerating into pulseless electrical activity and cardiac arrest requiring appropriate resuscitation to achieve the return of spontaneous circulation. Both series of simulation cases were modifiable based on trainee level and had the ability to include ancillary emergency department staff. Results: Each simulation case was performed six times at our simulation center, with a total of 22 learners for the hydroxychloroquine case, and 14 for the oleander case. Through pre- and post-simulation confidence assessments, learners demonstrated increases in knowledge of toxidromes, evaluating pediatric overdoses, treating cardiac dysrhythmias, performing pediatric advanced life support, and managing post-arrest care. Learners also demonstrated improvements in recognizing the unique treatment of hydroxychloroquine and oleander toxicity, the toxic dose of both substances in a child, and the most common electrolyte anomaly seen in each toxicity. Discussion: Simulation training enables learners to manage rare and complex disease processes. These cases were designed to educate trainees in recognizing and treating rare overdoses of emerging “therapeutics” that were touted early in the COVID-19 pandemic.
- 21 June 2022
- Published by Springer Nature in Cureus
- Vol. 14 (6) , e26176
Open AccessControversial COVID-19 Cures: Hydroxychloroquine and Oleander Pediatric Ingestion Simulation Cases
Introduction: The use of hydroxychloroquine has dramatically increased since being touted as a potential therapeutic in combating coronavirus disease 2019 (COVID-19) caused by the SARS-CoV-2 virus. This newfound popularity increases the risk of accidental pediatric ingestion, whereby just one or two tablets causes morbidity and mortality from seizures, cardiac dysrhythmias, and cardiogenic shock. The unique management of hydroxychloroquine overdose makes it imperative for emergency medicine physicians to have familiarity with treating this condition. Similarly, during the COVID-19 pandemic, there have been publicized cases touting extracts of oleander as being a potential therapeutic against the illness. Since it is commonly available and potentially lethal ingestion with a possible antidote, we developed a simulation case based on the available literature. The two cases were combined to create a pediatric toxicology curriculum for emergency medicine residents and medical students. Both of these treatments were selected as simulation cases since they were being touted by prominent national figures as potential cures for COVID-19. Methods: Two series of simulation cases were conducted in a high-fidelity simulation lab with emergency medicine residents and medical students. The hydroxychloroquine simulation case involved the management of a four-year-old male who presented to the emergency department with nausea, vomiting, and tachycardia after ingesting hydroxychloroquine tablets. As the case unfolded, the child became increasingly unstable, eventually experiencing QT prolongation, torsades de pointes, and ventricular fibrillation arrest requiring appropriate resuscitation to achieve a return of spontaneous circulation. The oleander simulation case involved the management of a three-year-old male who presented to the emergency department with nausea, vomiting, and tachycardia after ingesting parts of an unknown plant. As that case progresses, the child becomes increasingly unstable, eventually experiencing atrial fibrillation, bradycardia, and degenerating into pulseless electrical activity and cardiac arrest requiring appropriate resuscitation to achieve the return of spontaneous circulation. Both series of simulation cases were modifiable based on trainee level and had the ability to include ancillary emergency department staff. Results: Each simulation case was performed six times at our simulation center, with a total of 22 learners for the hydroxychloroquine case, and 14 for the oleander case. Through pre- and post-simulation confidence assessments, learners demonstrated increases in knowledge of toxidromes, evaluating pediatric overdoses, treating cardiac dysrhythmias, performing pediatric advanced life support, and managing post-arrest care. Learners also demonstrated improvements in recognizing the unique treatment of hydroxychloroquine and oleander toxicity, the toxic dose of both substances in a child, and the most common electrolyte anomaly seen in each toxicity. Discussion: Simulation training enables learners to manage rare and complex disease processes. These cases were designed to educate trainees in recognizing and treating rare overdoses of emerging “therapeutics” that were touted early in the COVID-19 pandemic.
- 1 January 2022
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 51, 103-107
Age adjusted D-dimer cutoffs for pulmonary embolism in a geriatric population utilizing a D-dimer unit assay
- 1 January 2022
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 51, 103-107
Age adjusted D-dimer cutoffs for pulmonary embolism in a geriatric population utilizing a D-dimer unit assay
- Open Access
- 15 June 2020
- Published by Western Journal of Emergency Medicine in Clinical Practice and Cases in Emergency Medicine
- Vol. 4 (3) , 389-392
Euglycemic Diabetic Ketoacidosis Precipitated by SGLT-2 Inhibitor Use, Pericarditis, and Fasting: A Case Report
Introduction: Diabetic ketoacidosis (DKA) is a potentially life-threatening complication of diabetes mellitus. Less prevalent is euglycemic DKA (eDKA)—DKA with serum glucose less than 200 mg/dL; however, it is increasing in frequency with the introduction of sodium glucose cotransporter 2 (SGLT-2) inhibitors for treatment of type 2 diabetes. Case Report: We report a case of SGLT-2 inhibitor-associated eDKA presenting with concurrent acute pericarditis. Discussion: Our case suggests that the cause of eDKA can be multifactorial when decreased oral intake occurs in the setting of an acute cause of physiologic stress. Conclusion: Prompt recognition of eDKA in the emergency department may allow earlier diagnosis and treatment directed at one or more of its underlying causes.
- 15 June 2020
- Published by Western Journal of Emergency Medicine in Clinical Practice and Cases in Emergency Medicine
- Vol. 4 (3) , 389-392
Open AccessEuglycemic Diabetic Ketoacidosis Precipitated by SGLT-2 Inhibitor Use, Pericarditis, and Fasting: A Case Report
Introduction: Diabetic ketoacidosis (DKA) is a potentially life-threatening complication of diabetes mellitus. Less prevalent is euglycemic DKA (eDKA)—DKA with serum glucose less than 200 mg/dL; however, it is increasing in frequency with the introduction of sodium glucose cotransporter 2 (SGLT-2) inhibitors for treatment of type 2 diabetes. Case Report: We report a case of SGLT-2 inhibitor-associated eDKA presenting with concurrent acute pericarditis. Discussion: Our case suggests that the cause of eDKA can be multifactorial when decreased oral intake occurs in the setting of an acute cause of physiologic stress. Conclusion: Prompt recognition of eDKA in the emergency department may allow earlier diagnosis and treatment directed at one or more of its underlying causes.